Literature DB >> 10680728

Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies.

D Sali1, P Boffetta.   

Abstract

OBJECTIVE: To study the risk of kidney cancer following asbestos exposure.
METHODS: We carried out a meta-analysis of the results of cohort studies of workers predominantly exposed to asbestos. We contacted the authors of 70 cohort studies; published results were available from the reports of 10 cohorts; we obtained the relevant information for an additional 27 cohorts.
RESULTS: The studies included in the analysis comprised a total of 169 kidney cancer deaths and 69 incident cases. The overall pooled standardized mortality ratio (SMR) of kidney cancer was 1.1, with a 95% confidence interval (95% CI) of 0.9-1.3. The pooled SMR was higher for workers with undefined asbestos exposure (SMR 1.2, 95% CI 0.9-1.6) than for workers with either predominant chrysotile (SMR 0.9, 95% CI 0.7-1.3) or some amphibole (SMR 0.96, 95% CI 0.6-1.5) exposure. Studies with published results had higher SMRs than studies for which information was obtained from the authors. Studies with high asbestos exposure and an elevated SMR of lung cancer tended to show an increased risk of kidney cancer.
CONCLUSIONS: It is unlikely that asbestos exposure is responsible for an important increase in kidney cancer risk; however, high asbestos exposure might entail a small increase in risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680728     DOI: 10.1023/a:1008905302597

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  10 in total

1.  Mortality from all cancers of asbestos factory workers in east London 1933-80.

Authors:  G Berry; M L Newhouse; J C Wagner
Journal:  Occup Environ Med       Date:  2000-11       Impact factor: 4.402

2.  Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS).

Authors:  Shannon M Lynch; Rajeev Mahajan; Laura E Beane Freeman; Jane A Hoppin; Michael C R Alavanja
Journal:  Environ Res       Date:  2009-07-16       Impact factor: 6.498

3.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

4.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

5.  Occupational exposure to dusts and risk of renal cell carcinoma.

Authors:  S Karami; P Boffetta; P S Stewart; P Brennan; D Zaridze; V Matveev; V Janout; H Kollarova; V Bencko; M Navratilova; N Szeszenia-Dabrowska; D Mates; J Gromiec; A Slamova; W-H Chow; N Rothman; L E Moore
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

6.  Concurrent occurrence of renal cell carcinoma with rhabdoid features in a married couple: a case report.

Authors:  Ryuji Matsumoto; Nobuo Shinohara; Kanako C-Hatanaka; Naoto Kuroda; Kunihiko Tsuchiya; Satoru Maruyama; Takashige Abe; Katsuya Nonomura
Journal:  BMC Res Notes       Date:  2015-01-15

Review 7.  Occupational exposure to respirable crystalline silica and chronic non-malignant renal disease: systematic review and meta-analysis.

Authors:  Matthias Möhner; Anne Pohrt; Johannes Gellissen
Journal:  Int Arch Occup Environ Health       Date:  2017-04-13       Impact factor: 3.015

Review 8.  Renal cell carcinoma: links and risks.

Authors:  Reena Kabaria; Zachary Klaassen; Martha K Terris
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-03-07

9.  Workplace exposure to asbestos and the risk of kidney cancer in Canadian men.

Authors:  Cheryl E Peters; Marie-Élise Parent; Shelley A Harris; Linda Kachuri; Lidija Latifovic; Laura Bogaert; Paul J Villeneuve
Journal:  Can J Public Health       Date:  2018-09-17

Review 10.  Occupational exposure to asbestos and risk of kidney cancer: an updated meta-analysis.

Authors:  Carlotta Zunarelli; Alessandro Godono; Giovanni Visci; Francesco S Violante; Paolo Boffetta
Journal:  Eur J Epidemiol       Date:  2021-06-30       Impact factor: 8.082

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.